Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 7, 2022--
The "Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
The report enables you to:
Scope
Key Topics Covered:
1 Table of Contents
2 Introduction
3 Products under Development
3.1 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
3.2 Vitreo Retinal Surgery Devices - Pipeline Products by Territory
3.3 Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path
3.4 Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date
3.5 Vitreo Retinal Surgery Devices - Ongoing Clinical Trials
4 Vitreo Retinal Surgery Devices - Pipeline Products under Development by Companies
4.1 Vitreo Retinal Surgery Devices Companies - Pipeline Products by Stage of Development
4.2 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
5 Vitreo Retinal Surgery Devices Companies and Product Overview
5.1 ABVC BioPharma Inc Company Overview
5.2 AcuSurgical Company Overview
5.3 Alcon Inc Company Overview
5.4 Bausch & Lomb Inc Company Overview
5.5 Beaver-Visitec International Inc Company Overview
5.6 Boston College Company Overview
5.7 Cambridge Polymer Group Inc Company Overview
5.8 Carnegie Mellon University Company Overview
5.9 Duke University Company Overview
5.10 Dutch Ophthalmic Research Center International BV Company Overview
5.11 Johns Hopkins University Company Overview
5.12 King's College London Company Overview
5.13 Medisse BV (Inactive) Company Overview
5.14 RetinaSense Company Overview
5.15 Synergetics USA, Inc. (Inactive) Company Overview
5.16 The Chinese University of Hong Kong Company Overview
5.17 University of Kansas Company Overview
5.18 University of Minnesota Company Overview
6 Vitreo Retinal Surgery Devices- Recent Developments
7 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/zd122m
Source: GlobalData
View source version on businesswire.com:https://www.businesswire.com/news/home/20221107005890/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: TECHNOLOGY HEALTH OPTICAL HEALTH TECHNOLOGY OTHER SCIENCE OTHER TECHNOLOGY MEDICAL DEVICES RESEARCH SURGERY SCIENCE CLINICAL TRIALS
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/07/2022 12:00 PM/DISC: 11/07/2022 12:02 PM
http://www.businesswire.com/news/home/20221107005890/en